(Reuters) -All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals, whose medicines are part of the second ...
Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...
An opaque system of rebates and discounts makes understanding a drug’s true price near impossible, even for experts. Can ...
A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's ...
In their own responses to the senators’ inquiries last fall, both Pfizer and Lilly emphasized the independence of their ...
The bill (LB168) from Sen. Brian Hardin of Gering would prohibit drugmakers from restricting the sale of medications included ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback